Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
A randomized, open-label, multiple-center, parallel group study to compare the platelet inhibition with VerifyNow assay of ticagrelor versus clopidogrel in troponin negative Acute Coronary Syndrome (ACS) subjects undergoing Ad Hoc percutaneous coronary intervention (PCI)
Age
18–130
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of signed and dated informed consent before initiation of any study-related procedures
Male or female patients aged 18 years or older
Documented acute coronary syndrome and troponin negative and undergoing Ad Hoc percutaneous coronary intervention (PCI)
Females must be post menopausal or surgically sterile
Taking aspirin as an anti-platelet medication
You may not be if
Use of any thienopyridine or ticagrelor within 7 days prior to randomization
Any indication for oral anticoagulant (e.g., atrial fibrillation, mitral stenosis or prosthetic heart valve)
Contraindication that ticagrelor or clopidogrel should not be administered Patient requires dialysis
